Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Biotech Model Is “Recipe For Success” In Asia – BIO Senior Officials

This article was originally published in PharmAsia News

Executive Summary

Asian countries looking to develop their biotech industries should look to the U.S. model as a framework for structuring regulations, especially intellectual property regimes, senior officials at the U.S. Biotechnology Industry Organization said in an interview with PharmAsia News

You may also be interested in...



Thailand’s Ministers Of Health, Commerce And Foreign Affairs Conclude Compulsory Licensing Legal

PERTH, Australia - A plan by Thailand's new Public Health Minister Chaiya Sasomsab to review the country's policy on compulsory licensing for four cancer drugs has stalled again after three ministry officials said the policy could not be revoked, the Bangkok Post reported Feb. 20

Insider Analysis: The Glivec Patent Saga – Effectuating “Efficacious” Patent Norms In India

By: Shamnad Basheer

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

MT125590

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel